Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor timing for stem cell mobilization
NCT01149863Phase 2Completed
- Sponsor
- Emory University
- Start
- Jun 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of plerixafor in multiple myeloma (MM), sponsored by Emory University. Primary endpoint: Number of Patients Who Collected ≥ 6 x 10^6 CD34+ Cells by Day 5. Started Jun 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01149863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149863.